Medicine & Life Sciences
Parkinsonian Disorders
57%
Synucleinopathies
54%
Dementia
42%
Cognitive Dysfunction
27%
Alzheimer Disease
26%
Population
21%
Amyloid
21%
REM Sleep Behavior Disorder
19%
Incidence
19%
Biomarkers
16%
Multiple System Atrophy
15%
Pathology
15%
Frontotemporal Dementia
15%
Gait
15%
Brain
14%
Movement Disorders
13%
Case-Control Studies
13%
Lewy Bodies
13%
Synucleins
12%
Progressive Supranuclear Palsy
11%
Levodopa
11%
Positron-Emission Tomography
11%
Constipation
11%
Hyperphosphatemia
11%
Islands
10%
Amyotrophic Lateral Sclerosis
10%
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
10%
Epidemiology
10%
Chromosomes, Human, Pair 9
10%
Deep Brain Stimulation
10%
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
10%
Phenotype
10%
Stroke
9%
Mutation
9%
Cohort Studies
9%
Medical Record Linkage
9%
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
9%
Tremor
8%
Autopsy
8%
Age of Onset
8%
TimeLine
8%
Medical Records
8%
Neurodegenerative Diseases
8%
Neuroimaging
7%
Secondary Parkinson Disease
7%
Fluorodeoxyglucose F18
7%
Atrophy
7%
Dyskinesias
7%